Imamura, FumiakiSharp, Stephen JKoulman, AlbertSchulze, Matthias BKröger, JanineGriffin, Julian LHuerta, José MGuevara, MarcelaSluijs, IvonneAgudo, AntonioArdanaz, EvaBalkau, BeverleyBoeing, HeinerChajes, VeroniqueDahm, Christina CDow, CourtneyFagherazzi, GuyFeskens, Edith J MFranks, Paul WGavrila, DianaGunter, MarcKaaks, RudolfKey, Timothy JKhaw, Kay-TeeKühn, TilmanMelander, OlleMolina-Portillo, ElenaNilsson, Peter MOlsen, AnjaOvervad, KimPalli, DomenicoPanico, SalvatoreRolandsson, OlovSieri, SabinaSacerdote, CarlottaSlimani, NadiaSpijkerman, Annemieke M WTjønneland, AnneTumino, Rosariovan der Schouw, Yvonne TLangenberg, ClaudiaRiboli, ElioForouhi, Nita GWareham, Nick J2018-04-042018-04-042017-10A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study. 2017, 14 (10):e1002409 PLoS Med.1549-16762902005110.1371/journal.pmed.1002409http://hdl.handle.net/10029/621737Combinations of multiple fatty acids may influence cardiometabolic risk more than single fatty acids. The association of a combination of fatty acids with incident type 2 diabetes (T2D) has not been evaluated.enArchived with thanks to PLoS medicineBiomarkersCase-Control StudiesCohort StudiesCross-Sectional StudiesDiabetes Mellitus, Type 2EuropeFatty AcidsFemaleHumansIncidenceInternationalityMaleMiddle AgedPhospholipidsPrincipal Component AnalysisProspective StudiesRandom AllocationArticlePlos Med 2017; 14(10):e1002409